A. Farris

2.5k citations

81 papers · 1.6k indexed · h-index 23

Impact in

Cancer Research top 5%
- Breast Cancer Treatment Studies
Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies

Papers in ⓘ

Oncology 56
- Cancer Treatment and Pharmacology 38
- Colorectal Cancer Treatments and Studies 21
- HER2/EGFR in Cancer Research 5
Cancer Research 18
- Breast Cancer Treatment Studies 16

Co-authors: Luigi Maiorino (15 shared papers)Giorgio Mustacchi (11 shared papers)A. De Matteis (6 shared papers)B. Massidda (16 shared papers)A. Scanni (4 shared papers)Alfonso M. Pluchinotta (3 shared papers)Francesco Boccardo (9 shared papers)Vito Lorusso (10 shared papers)
Journals: Journal of Clinical Oncology (11 papers)Annals of Oncology (8 papers)British Journal of Cancer (6 papers)Journal of Chemotherapy (5 papers)Cancer (4 papers)
Partner nations: Italy United Kingdom United States

In The Last Decade

A. Farris

80 papers receiving 1.6k citations

Peers

Countries citing papers authored by A. Farris

Since Specialization

Citations

This map shows the geographic impact of A. Farris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Farris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Farris more than expected).

Fields of papers citing papers by A. Farris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Farris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Farris. The network helps show where A. Farris may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Farris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Farris Line = papers co-authored together A. Farris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial Annals of Oncology ·Giorgio Mustacchi, Rita Ceccherini, Stefano Milani, Alfonso M. Pluchinotta, A. De Matteis, Luigi Maiorino, A. Farris, A. Scanni, Franco Sasso	2003	146
2	Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa Journal of Clinical Oncology ·Paolo Pedrazzoli, A. Farris, Salvatore Del Prete, Filomena Del Gaizo, Daris Ferrari, Clara Bianchessi, Giuseppe Colucci, A Desogus, Teresa Gamucci, Alessandro Pappalardo, Giuseppe Fornarini, Paola Pozzi, Alessandra Fabi, Roberto Labianca, Francesco Di Costanzo, Simona Secondino, E. Crucitta, Federica Apolloni, Antonio Santo, Salvatore Siena	2008	131
3	Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial Journal of Clinical Oncology ·Francesco Boccardo, A. Rubagotti, D. Amoroso, M. Mesiti, D Romeo, P Sismondi, M Giai, Franco Tarro Genta, P Pacini, V. Distante, Angelo Bolognesi, D. Aldrighetti, A. Farris, (unknown)	2000	125
4	Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design Journal of Clinical Oncology ·Alfredo Berruti, Raffaella Bitossi, G. Gorzegno, Alberto Bottini, P Alquati, A. De Matteis, Francesco Nuzzo, Giorgio Giardina, Saverio Danese, Mario De Lena, Vito Lorusso, A. Farris, Maria Giuseppa Sarobba, E Defabiani, G Bonazzi, Federico Castiglione, C. Bumma, Gregorio Moro, Paolo Bruzzi, Luigi Dogliotti	2002	74
5	Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma Cancer ·Pasquale Comella, D. Natale, A. Farris, Antonio Gambardella, Luigi Maiorino, B. Massidda, Rossana Casaretti, Salvatore Tafuto, Vito Lorusso, Silvana Leo, Michele Cannone	2005	69
6	Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease British Journal of Cancer ·Marco Tampellini, Alfredo Berruti, Aldo Gerbino, T. Buniva, M. Torta, G. Gorzegno, R. Faggiuolo, R. Cannone, A. Farris, M. Destefanis, G Moro, Francesco Deltetto, Luigi Dogliotti	1997	69
7	Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer European Journal of Cancer ·Andrea Martoni, Antonella Marino, Francesca Sperandi, S. Giaquinta, Francesca Di Fabio, Barbara Melotti, M. Guaraldi, Giuseppe Palomba, P. Preti, Antonino Petralia, Fabrizio Artioli, Vincenzo Picece, A. Farris, LG Mantovani	2004	61
8	Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer Patients: Results of an Italian Cooperative Study Journal of Clinical Oncology ·Francesco Boccardo, A. Rubagotti, D. Amoroso, M. Mesiti, D Romeo, C. Caroti, A. Farris, Giorgio Cruciani, E. Villa, Giorgio Schieppati, Giorgio Mustacchi	2001	56
9	In Vitro Interaction between Ochratoxin A and Different Strains ofSaccharomyces cerevisiaeandKloeckera apiculata Journal of Agricultural and Food Chemistry ·Alberto Angioni, P. Caboni, Alessandra Garau, A. Farris, Davide Orro, Marilena Budroni, Paolo Cabras	2007	52
10	Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses British Journal of Cancer ·Cesare Gridelli, L. Frontini, Federica Perrone, Ciro Gallo, Marcella Gulisano, S. Cigolari, Fabiana Castiglione, Sergio Robbiati, Giampietro Gasparini, Giovanni Pietro Ianniello, A. Farris, M.C. Locatelli, Raffaella Felletti, E. Piazza	2000	51
11	Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial. Journal of Clinical Oncology ·Luigi Dogliotti, Alfredo Berruti, T. Buniva, Paolo Zola, Maria Grazia Baù, A. Farris, Maria Giuseppa Sarobba, Alberto Bottini, P Alquati, Francesco Deltetto, P Gosso, C. Monzeglio, G Moro, M Sussio, D. Perroni	1996	44
12	Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401 Journal of Cancer Research and Clinical Oncology ·Pasquale Comella, B. Massidda, Gianfranco Filippelli, A. Farris, D. Natale, Giuseppe Barberis, Luigi Maiorino, S. Palmeri, Michele Cannone, G. Condemi, (unknown)	2008	39
13	Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial Annals of Oncology ·P. Comella, B. Massidda, Gianfranco Filippelli, S. Palmeri, D. Natale, A. Farris, Ferdinando De Vita, Franco Buzzi, Salvatore Tafuto, Luigi Maiorino, S. Mancarella, Silvana Leo, Vito Lorusso, Lucia Liguori, Mario Roselli	2005	38
14	Identification of a founder BRCA2 mutation in Sardinia British Journal of Cancer ·Marina Pisano, Antonio Cossu, Ivana Persico, Giuseppe Palmieri, Andrea Angius, Giuseppina Casu, Grazia Palomba, Maria Giuseppa Sarobba, (unknown), Maria Filomena Dedola, N. Olmeo, Sorin Aurelian Pașca, Mario Budroni, V Marras, Agata Pisano, A. Farris, Giovannino Massarelli, Mario Pirastu, Francesco Tanda	2000	32
15	Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients Breast Cancer Research and Treatment ·Marco Tampellini, Alfredo Berruti, Raffaella Bitossi, G. Gorzegno, Irene Alabiso, Alberto Bottini, A. Farris, Michela Donadio, Maria Giuseppa Sarobba, E Manzin, Antonio Durando, E Defabiani, A. De Matteis, Mara Ardine, Federico Castiglione, Saverio Danese, Elena Bertone, Oscar Alabiso, M Massobrio, Luigi Dogliotti	2006	29
16	A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. PubMed ·Federica Tomao, Adriana Romiti, B. Massidda, Maria Teresa Ionta, A. Farris, Angelo Zullo, Antonio Brescia, L. Santuari, Luigi Frati	2002	26
17	Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer Lung Cancer ·Andrea Martoni, M. Guaraldi, E Piana, Elena Strocchi, Antonino Petralia, L. Busutti, P. Preti, G. Robustelli della Cuna, M Raimondi, Giuseppe Ferrara, Giuseppe Palomba, G. Lelli, Vincenzo Picece, E. Recaldin, Orazio Caffo, G. Ambrosini, Giuseppina Sarobba, A. Farris, F Pannuti	1998	25
18	Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital‐based screening Cancer ·Grazia Palomba, Marina Pisano, Antonio Cossu, Mario Budroni, Maria Filomena Dedola, A. Farris, A. Contu, Paola Baldinu, Francesco Tanda, Giuseppe Palmieri	2005	24
19	Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer Oncology ·Andrea Martoni, E Piana, M. Guaraldi, Giuseppina Cilenti, A. Farris, F Saccani, Giorgio Becchi, F Pannuti	1990	24
20	A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer British Journal of Cancer ·(unknown), Sabino De Placido, Michelino De Laurentiis, M. De Lena, Vito Lorusso, Angelo Paradiso, Modesto DʼAprile, Giorgio Pistillucci, A. Farris, Maria Giuseppa Sarobba, S. Palazzo, Luigi Manzione, Vincenzo Adamo, S. Palmeri, Francesco Ferraù, Rossella Lauria, Caterina Pagliarulo, Giuseppe Petrella, Gennaro Limite, Raffaele Costanzo, Antonio Bianco	2005	24

About A. Farris

A. Farris is a scholar working on Oncology, Cancer Research, Hepatology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (38 papers), Colorectal Cancer Treatments and Studies (21 papers), Breast Cancer Treatment Studies (16 papers), Gastric Cancer Management and Outcomes (11 papers), Estrogen and related hormone effects (10 papers), Lung Cancer Treatments and Mutations (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (599 citations), Oncology (949 citations), Hematology (145 citations), Genetics (353 citations) and Pulmonary and Respiratory Medicine (408 citations). A. Farris has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Luigi Maiorino, Giorgio Mustacchi, A. De Matteis, B. Massidda, A. Scanni, Alfonso M. Pluchinotta, Francesco Boccardo, Vito Lorusso, Luigi Dogliotti and A. Rubagotti. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Journal of Chemotherapy and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact